High triglycerides increase cardiovascular events, medical costs, and resource utilization in a real - world analysis of statin - treated patients with high cardiovascular risk and well - controlled low - density lipoprotein cholesterol [abstra
High triglycerides increase cardiovascular events, medical costs, and resource utilization in a real - world analysis of statin -
treated patients with
high cardiovascular risk and well - controlled low - density lipoprotein cholesterol [abstra
high cardiovascular risk and well - controlled low - density lipoprotein cholesterol [abstract].
A new study shows that the drug fenofibrate might reduce the risk of cardiovascular events in patients with type 2 diabetes who have
high levels of
triglycerides and low levels of «good» cholesterol, despite being
treated with statins.